Transoral and Transcervical Surgical Innovations in the Treatment of Glottic Cancer.

Steven M Zeitels

Journal: Otolaryngologic clinics of North America 2016;48(4):677-85

PMID: 26233792

Full Text on Elsevier Science View on PubMed

Abstract

Transoral and transcervical surgery to treat glottic cancer has advanced substantially over the past decade. There have been considerable innovations that enhance vocal function for early disease and airway function for advanced disease. The fiber-based angiolytic 532 nm potassium titanyl phosphate laser has provided a new foundational strategy to maintain high cure rates with enhanced vocal outcomes for the treatment of early glottic disease. For advanced glottic cancer, transplanting cryopreserved aortic homograft to reconstruct wide-field laryngotracheal airway defects can provide an adequate airway caliber such that a long-term tracheotomy can frequently be avoided.

Address: Division of Laryngeal Surgery, Massachusetts General Hospital, Harvard Medical School, One Bowdoin Square, Boston, MA 02114, USA. Electronic address: [email protected].

DOI: 10.1016/j.otc.2015.04.012

Link outs

Free resources

Miscellaneous:

https://assays.cancer.gov/CPTAC-68

Subscription / membership required

Full Text Sources:

MeSH Terms: Carcinoma, Squamous Cell, Humans, Laryngeal Neoplasms, Laryngectomy, Laser Therapy, Lasers, Solid-State, Organ Sparing Treatments, Treatment Outcome, Vocal Cords, Voice Quality